We have recently reported that adenovirus replication is inhibited by human recombinant interferon-y, but not by recombinant interferon-cq in a dose-dependent manner. The aim of this study was to determine whether the antiviral effect of recombinant interferon-~ could be linked to interferon-induced alteration at the membrane level, inhibiting either adenovirus penetration of or release from WISH cells. Adsorption and penetration were investigated with an 12SI-labelled adenovirus binding assay. To test defective virus release, the presence of newly synthesized virus proteins in the cytoplasmic and nuclear compartments was investigated. Binding studies showed that interferons-7 and -a did not modify adenovirus attachment and penetration. Interferon-y but not interferon-a inhibited hexon protein synthesis in the cytosol as well as its accumulation in the nuclear compartment. The synthesis of polypeptides III, IV and VI was also inhibited. In cells infected before interferon-7 treatment, its addition could be delayed up to 2 h after the infection to produce an inhibition of virus yield greater than 1 log10 unit (90~ inhibition). We conclude that interferon-y acts on an intracellular step before or at adenovirus protein synthesis, probably through a mechanism not shared with interferon-a.
Many antiviral activities have been described for interferons (IFNs)-~ and -y (for reviews, see Lengyel, 1982; Jacobsen, 1986) , and these affect almost every step in the replication of different viruses. However, up to the present, most studies have been performed with IFN-c~ or -fl, the action of IFN-y being less well known.
In a previous report (Mistchenko & Falcoff, 1987) , we showed that human recombinant IFN-y (rIFN-y), but not rIFN-~ or -fl, inhibited the replication of different human adenovirus serotypes in several human cell lines in vitro. The adenovirus system provides, in our opinion, a useful tool for research into IFN-y-restricted antiviral activity. We decided to study the underlying antiviral mechanism(s), beginning the search by investigating the membraneassociated events. It is known that IFNs induce changes in membrane fluidity (Chatterjee et al., 1982) which could hypothetically modify adenovirus penetration or release. There is evidence that IFN-a induces 50~o inhibition of vesicular stomatitis virus penetration (Whitaker-Dowling et al., 1983) . In cells infected with herpes simplex virus (Chatterjee et al., 1985) , IFNs-a and -fl inhibit virus release, resulting in intracellular accumulation of virus components. The effect of interferon on retrovirus multiplication is controversial. Some authors have described an intracellular accumulation of viral products or particles (reviewed by Friedman & Pitha, 1984) while others have reported the accumulation of viral particles adhering to the outer membrane (Billiau et al., 1976) . In the particular case of adenovirus, its penetration has been shown to depend upon membrane characteristics such as fluidity (Boulanger & Philipson, 1981 In order to study adenovirus binding to cells or viral protein synthesis therein, human amniotic WISH cells (Flow Laboratories) were cultured as monolayers in Eagle's M E M (Boehringer) supplemented with 10% foetal calf serum (Flow), 2 mM-glutamine (Gibco) and 1 mg/l non-essential amino acids (Seromed, Munich, F.R.G.), referred to as complete medium. Adenovirus serotype 5 was propagated in WISH cells. For radiolabelling and binding studies, it was further purified on two sequential CsC1 gradients, reaching a titre of 3 × 10 ~2 TCIDso/ml. Virus iodination (1251, Oris, France) was accomplished with chloramine-T (0-05 gg/ml final concentration) as the oxidizing agent followed by free iodine elimination by filtration on a PD-10 column (Pharmacia). The specific radioactivity of labelled adenovirus ranged between 2.2 x 108 and 3.8 x 108 particles per gCi. S D S -P A G E of iodinated virus showed only labelled capsid polypeptides.
Human rlFN-y (Roussel-Uclaf, France; sp. act. 4 x 107 U/mg protein) and rlFN-~2b
(Schering-Plough Corp., U.S.A.; 2 x l08 U/mg protein) both produced in Escherichia coli, were used at 700 U/ml and 1000 U/ml respectively, for overnight incubation. For attachment studies, dose-response relationships were estimated by incubation of cells with iodinated adenovirus at different m.o.i., in triplicate, for 90 min at 4 °C. After washing with ice-cold complete medium, cells were lysed with 1% SDS and y-ray emission was measured (LKB Multi-gamma counter). The binding time-course was determined for a fixed multiplicity (100) with different incubation times at 4°C or at 37 °C.
The study of adenovirus structural polypeptides present within the cells was done by SDS-P A G E analysis of cytoplasmic and nucleoplasmic extracts after 35S pulse-labelling at 21 h after infection. SDS-PAGE was performed directly or after immunoprecipitation with an anti-hexon serum raised in a rabbit by immunization with adenovirus 2 hexon purified according to Pereira et al. (1968) . Gel slabs were autoradiographed on Kodak XS5 films. Immunoprecipitations were analysed by fluorography. The obvious first step in the analysis of rlFN-y action was to evaluate whether virus attachment or internalization were modified by rlFN-y. The binding of adenovirus to WISH monolayers was first determined at different multiplicities. At m.o.i, between 100 and 1000, neither IFN-~ nor IFN-y modified adenovirus binding at 37 °C (data not shown). The time course of adenovirus-WISH cell interaction at 4 °C or at 37 °C is illustrated in Fig. 1 . Binding was time-dependent and rlFN-y was unable to modify it. Cell-associated radioactivity at 90 min represented, at 37 °C, about 15 % of the added virus. The corresponding values were four-to fivefold lower at 4 °C, the difference probably reflecting virus internalization at 37 °C. To test whether adenovirus binding corresponded to specific attachment to the cell surface, binding experiments were performed after the cells had been treated with an excess of unlabelled adenovirus (Lonberg-Holm et al., 1976) . Iodinated virus binding was partially reduced (about 30%) at 60min. Again, rlFN-y did not modify adenovirus binding (data not shown). Adenovirus interaction with its attachment proteins has been analysed in detail in the HeLa system (for review, see Boulanger & Philipson, 1981) . Our results with WISH cells are in agreement with descriptions of early events in adenovirus infection. The adenovirus binding was specific, and time-and multiplicity-dependent, both at 4 °C or at 37 °C. rlFN-y did not modify binding in any of the assays performed. Moreover, as illustrated in Table 1 , its antiviral action could be detected even when the drug was added after infection of the culture, although to a lesser extent.
Regarding adenovirus protein synthesis, Table 2 presents a representative experiment in which untreated cells, between 12 and 18 h after challenge, incorporated about 25% less [35S]methionine than the uninfected control. The apparent reversal of this inhibition at 24 h may reflect the high production rate of hexon protein. This was barely detected at 18 h but at 24 h, in densitometric scans of SDS-PAGE autoradiographs, constituted up to 30% of the protein synthesized without apparent changes in the pattern of newly synthesized cellular proteins (data not shown). The slight shut-off of total protein synthesis which resulted from adenovirus infection was not observed in cultures pretreated with rlFN-y. Fig. 2 clearly shows that IFN-y inhibits the synthesis of major adenovirus proteins, whereas IFN-~ has no marked action. The lack of anti-adenovirus action of rlFN-~ suggests that the effect of rlFN-y depends on some mechanism(s) not shared by rlFN-a. The possibility of rlFN-y acting by a different antiviral mechanism was previously discussed by Rubin & Gupta (1980) , who showed that vaccinia virus and reovirus were sensitive to IFN-y but not to IFN-a. Weil et al. (1983) have shown the synthesis after rIFN-7 treatment of at least eight polypeptides not induced by rIFN-e. Antiviral states induced by IFN-cc/fl and IFN-y have been shown to be regulated with different kinetics, for both induction and extinction (Ramamurthy & Fleischmann, 1986) . In the case of adenovirus, resistance to the effects of IFN-a has been reported to depend on inhibition of the IFN-induced eIF-2c~ kinase activity by the viral VAI RNA (Kitajewski et al., 1986) . This implies that involvement of eIF-2c¢ kinase is not likely in the mechanism of the anti-adenovirus action of rIFN-?,. However, relevant differences in the induction and regulation of the enzyme, such as those reported by Faltynek et al. (1985) can not be completely excluded. Lane (e) in Fig. 2 shows the prevention of induction of the anti viral state when cells had been treated simultaneously with cycloheximide and rIFN-~, which were removed at the moment of infection. Cell extracts were prepared 21 h after challenge. The inhibition of rIFN-y antiviral activity by cycloheximide is consistent with previous reports in other viral systems (Dianzani et at., 1980) . Analysis of the major peptides of adenovirus capsids by SDS-PAGE is illustrated in Fig. 3 . After 24 h of infection at least the hexon, penton and fibre proteins in the cytoplasmic compartment of infected untreated cells were clearly detected. The same was the case for the small adenovirus polypeptide VI (the so-called hexon-associated protein, Mr 24000), which was more visible in a 10 to 20~o gel. Lanes 4 in Fig. 3 (a) and 3 in Fig. 3(b) represent a simultaneous study of infected cells pretreated with 700 U/ml rlFN-~. The absence of viral proteins is clear, and the pattern is very similar to that of uninfected cells pretreated with rlFN-),. The synthesis of these viral proteins is a well characterized cytoplasmic event (for review, see Esche et al., 1984) which precedes their translocation to the cell nucleus and virus assembly. The absence of viral proteins in the cytoplasm could be due to an increased transport to the nucleus. We looked therefore for hexon accumulation in the nuclear compartment. Fig. 3(c) shows the immunoprecipitation of nuclear proteins with anti-hexon antibody: the only band is seen in lane 3, which corresponds to untreated infected ceils, whereas rlFN-7-treated cells are similar to control cells. The lack of hexon protein in the nuclear compartment seems to rule out that possibility. Taken together, the inhibition of viral protein synthesis and the lack of effect on adenovirus adsorption and entry suggest that rlFN-y action against adenovirus is linked to event(s) occurring between the two steps studied.
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